Use of Impella® Device During High-Risk PCI is Associated with Reduced Occurrence of Acute Kidney Injury
Patients undergoing complex coronary revascularization are at risk for periprocedural and postprocedural acute kidney injury (A...
IMPRESS in Severe Shock Trial: Looking Closer at the Data
For patients with cardiogenic shock (CS), intra-aortic balloon pump (IABP) had been an important tool for maintaining patients...
IABP vs Impella®: Incidence of Bleeding and Vascular Complications
Key TakeawaysPatients undergoing high-risk PCI often require additional hemodynamic...
Detroit Cardiogenic Shock Initiative: Initial Results
Data presented by Dr. William O'Neill of Henry Ford Hospital System at the 66th Annual Scientific Session of the American Colle...
Impella® Quality Assurance Program: Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery
Data from Abiomed’s Impella® Quality (IQ) Assurance Program, which includes the IQ Database and cVAD Registry, wa...
The Benefit of Impella® Support During Protected PCI for Revascularization
Drs. John Lasala, Bill O’Neill, Jeff Moses, and Bill Lombardi explain the benefit of Impella support during Protected PCI for...
How to Start Your Own Protected PCI Program
Dr. Perwaiz Meraj of North Shore University Hospital in Long Island shares his Protected PCI program experiences. He also provi...
The Evolving Landscape of CAD Treatment for Patients with an Indication for Revascularization
More than 15 million Americans suffer from coronary artery disease (CAD), the leading cause of mortality in the United States....
Why Complete Revascularization Should be the Standard for Most High-Risk PCI Cases, Dr. Jeffrey Moses
Dr. Jeffrey Moses, Director of Interventional Cardiac Therapeutics at Columbia University Medical Center, NY and Director of Co...
Device Options, Patient Managment and Case Reviews
Ochsner Medical Center's Dr. Rajan Patel presents practical Impella use and management strategies, and also tips and tricks at...
How to Best Identify Cardiogenic Shock Patients
Watch as Dr. Seth D. Bilazarian, Abiomed's VP of Interventional Cardiology, discusses the field of cardiogenic shock and how to...
Impella Best Practices Based on 10 Years of Experience
The ProtectedPCI.com blogging team spoke with the Academic Medical Center's Dr. Jose Henriques at the European Advanced Hemodyn...
Starting Shock Treatment Program Using Advanced Hemodynamic Support
The ProtectedPCI.com blogging team spoke with Dr. Bernhard Schieffer from Marburg at the European Advanced Hemodynamics course...
How to Better Evaluate, Identify and Manage Shock Patients
Recently, Abiomed’s platform of Impella® heart pumps received FDA approval for the treatment of patients experiencing cardiogen...
New Definition of High Risk Patient and Other Highlights from Day 1 of ACC 2016
Today the ACC 2016 Scientific Session and Expo kicked off in Chicago. Watch as Abiomed's VP of Interventional Cardiology Progra...
Congratulations to February and March 2016 Impella® Heart Team Certification Program Graduates
The Protected PCI™ Blogging Team wants to take a moment to recognize the physicians who recently completed the “Impella...
Dr. Navin Kapur Discusses pMCS devices at CHIP Course
As part of the “CHIP: Hemodynamic Support and...
Dr. Jeff Moses Illustrates Typical High-Risk Patient at CHIP Course
Nearly 100 interventional and clinical cardiologists from around the country gathered in Fort Lauderdale to collaborate and wat...
Latest Webinar on Building a Protected PCI Program Features the University of Washington Heart Center in Seattle
The Building a Protected PCI Program series* presents a webinar entitled “The Programmatic Approach to Teaching, Tactics and Te...
Building a Protected PCI Program Webinar Discusses the Heart Team Approach
The webinar* entitled “Building a Protected PCI Program: The Heart Team Approach” highlights the development and use of the hea...
Dr. Jeffrey Moses Discusses Three Key Areas of Patient Concerns
The Protected PCI blogging team recorded our latest podcast at the Abiomed Advanced Users course in Europe, where Dr. Jeffrey M...
Dr. William Lombardi Discusses Overcoming Impediments in Treating High-Risk Coronary Patients
In this podcast, Abiomed's Dr. Seth Bilazarian speaks with Dr. William Lombardi, a long-time expert in complex coronary interve...
Drs. Martin Leon and Dan Burkhoff Discuss Hemodynamics of Protected PCI with Impella
In the video below, the Cardiovascular Research Foundation presents a discussion between Drs. Martin Leon and Dan Burkhoff from...
Dr. John Lasala Discusses Benefits of Protected PCI at Scripps 2015
Protected percutaneous coronary intervention (PCI) with the...
Roundtable Discusses the Growing Need for Protected PCI
There is a growing need in the cath lab to treat more high risk patients, per the CHIP initiative. Dr. Ajay Kirtane, Dr. John L...
New Insights from PROTECT II Trial Discussed at TCT 2011
Hemodynamic Support in High Risk Patients Undergoing Extensive Revascularization: Dr. John Lasala, Dr. Jeff Moses, Dr. Bill O'N...
Protected PCI Offers New Option for Patients Turned Down for CABG or Traditional PCI
Improving the health of patients and offering the best possible treatments is the primary ethos and goal of any medical profess...
